Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment

Detalhes bibliográficos
Main Authors:	Panupong Mahalapbutr, Thanyada Rungrotmongkol
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2024-02-01
Colecção:	Frontiers in Drug Discovery
Assuntos:	EGFR cancer kinase inhibitor mutation anticancer drug
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fddsv.2024.1365318/full

Internet